What does CUSIP 917488108 represent in this 13F holders report?

CUSIP 917488108 is the security identifier for UTMD - UTAH MEDICAL PRODUCTS INC - Common Stock used to aggregate holder disclosures.

How many institutions held UTMD - UTAH MEDICAL PRODUCTS INC - Common Stock in Q2 2023?

89 institutional investors reported UTMD - UTAH MEDICAL PRODUCTS INC - Common Stock for Q2 2023. Use the holders table for investor-level position and value details.

UTAH MEDICAL PRODUCTS INC - Common Stock (UTMD)

CUSIP: 917488108

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class: Equity / Common Stock
Shares outstanding: 3,203,885
Total 13F shares: 2,546,722
Share change: +4,366
Total reported value: $237,462,990
Price per share: $93.20
Number of holders: 89
Value change: +$487,123
Number of buys: 39
Number of sells: 38

Quarterly Holders Quick Answers

What is CUSIP 917488108?
CUSIP 917488108 identifies UTMD - UTAH MEDICAL PRODUCTS INC - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2023
Previous quarter: Q1 2023

Recent filing periods for CUSIP 917488108:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of UTMD - UTAH MEDICAL PRODUCTS INC - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	12%	382,058	$36,207,637	—	31 Mar 2023	13F
T. Rowe Price Investment Management, Inc.	13F	Company	11%	349,840	$33,155,000	—	31 Mar 2023	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	6.5%	206,714	$19,590,000	—	31 Mar 2023	13F
BlackRock Finance, Inc.	13F	Company	6.2%	199,037	$18,862,738	—	31 Mar 2023	13F
Kevin L. Cornwell	3/4/5	Chairman, CEO, Secretary, Director	— class O/S missing	188,472	$17,774,794	—	22 Nov 2021	3/4/5
VANGUARD GROUP INC	13F	Company	5.3%	168,935	$16,009,969	—	31 Mar 2023	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	4.8%	154,538	$14,646,118	—	31 Mar 2023	13F
RICE HALL JAMES & ASSOCIATES, LLC	13F	Company	3.6%	114,123	$10,815,446	—	31 Mar 2023	13F
JPMORGAN CHASE & CO	13F	Company	2.7%	85,468	$8,099,000	—	31 Mar 2023	13F
Ranger Investment Management, L.P.	13F	Company	2.3%	72,525	$6,873,194	—	31 Mar 2023	13F
STATE STREET CORP	13F	Company	2.2%	71,446	$6,791,748	—	31 Mar 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	2.2%	71,411	$6,767,620	—	31 Mar 2023	13F
Russell Investments Group, Ltd.	13F	Company	2.2%	69,488	$6,585,376	—	31 Mar 2023	13F
LOOMIS SAYLES & CO L P	13F	Company	1.6%	51,520	$4,883,000	—	31 Mar 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	1.4%	43,460	$4,118,705	—	31 Mar 2023	13F
FRANKLIN RESOURCES INC	13F	Company	1.3%	41,696	$3,951,530	—	31 Mar 2023	13F
NORTHERN TRUST CORP	13F	Company	1.2%	37,846	$3,586,665	—	31 Mar 2023	13F
ROYCE & ASSOCIATES LP	13F	Company	1%	32,659	$3,095,093	—	31 Mar 2023	13F
Bank of New York Mellon Corp	13F	Company	0.97%	31,160	$2,953,040	—	31 Mar 2023	13F
Clean Yield Group	13F	Company	0.8%	25,683	$2,433,978	—	31 Mar 2023	13F
LSV ASSET MANAGEMENT	13F	Company	0.76%	24,500	$2,322,000	—	31 Mar 2023	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.72%	23,060	$2,187,000	—	31 Mar 2023	13F
Ancora Advisors LLC	13F	Company	0.69%	22,142	$2,098,397	—	31 Mar 2023	13F
BRANDES INVESTMENT PARTNERS, LP	13F	Company	0.67%	21,505	$2,038,029	—	31 Mar 2023	13F
ISTHMUS PARTNERS, LLC	13F	Company	0.66%	21,005	$1,990,644	—	31 Mar 2023	13F
MORGAN STANLEY	13F	Company	0.47%	15,152	$1,435,954	—	31 Mar 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.44%	14,253	$1,350,757	—	31 Mar 2023	13F
Penn Mutual Asset Management	13F	Company	0.44%	13,948	$1,321,852	—	31 Mar 2023	13F
EVERETT HARRIS & CO /CA/	13F	Company	0.43%	13,820	$1,309,721	—	31 Mar 2023	13F
Cardinal Capital Management	13F	Company	0.35%	11,166	$1,061,473	—	31 Mar 2023	13F
GLOBEFLEX CAPITAL L P	13F	Company	0.3%	9,710	$920,217	—	31 Mar 2023	13F
CITADEL ADVISORS LLC	13F	Company	0.29%	9,404	$891,217	—	31 Mar 2023	13F
Nuveen Asset Management, LLC	13F	Company	0.28%	8,839	$838,000	—	31 Mar 2023	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.25%	8,151	$772,000	—	31 Mar 2023	13F
SEIZERT CAPITAL PARTNERS, LLC	13F	Company	0.2%	6,269	$594,113	—	31 Mar 2023	13F
MORGAN DEMPSEY CAPITAL MANAGEMENT LLC	13F	Company	0.18%	5,893	$558,480	—	31 Mar 2023	13F
STRS OHIO	13F	Company	0.18%	5,800	$549,000	—	31 Mar 2023	13F
LOS ANGELES CAPITAL MANAGEMENT LLC	13F	Company	0.16%	5,262	$498,680	—	31 Mar 2023	13F
Ernst G. Hoyer	3/4/5	Director	— class O/S missing	5,000	$471,550	—	23 Nov 2021	3/4/5
Barbara A. Payne	3/4/5	Director	— class O/S missing	4,838	$456,272	—	08 Feb 2023	3/4/5
ALLIANCEBERNSTEIN L.P.	13F	Company	0.15%	4,700	$445,419	—	31 Mar 2023	13F
RHUMBLINE ADVISERS	13F	Company	0.14%	4,583	$434,000	—	31 Mar 2023	13F
MERCER GLOBAL ADVISORS INC /ADV	13F	Company	0.14%	4,479	$424,000	—	31 Mar 2023	13F
ROYAL BANK OF CANADA	13F	Company	0.14%	4,326	$409,000	—	31 Mar 2023	13F
JAMES INVESTMENT RESEARCH, INC.	13F	Company	0.13%	4,292	$407,000	—	31 Mar 2023	13F
Quadrature Capital Ltd	13F	Company	0.13%	4,048	$383,629	—	31 Mar 2023	13F
Penobscot Investment Management Company, Inc.	13F	Company	0.12%	4,000	$379,080	—	31 Mar 2023	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.12%	3,952	$374,531	—	31 Mar 2023	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.12%	3,700	$350,649	—	31 Mar 2023	13F
ENVESTNET ASSET MANAGEMENT INC	13F	Company	0.11%	3,654	$346,297	—	31 Mar 2023	13F

Institutional Holders of UTAH MEDICAL PRODUCTS INC - Common Stock (UTMD) as of Q2 2023

As of 30 Jun 2023, UTAH MEDICAL PRODUCTS INC - Common Stock (UTMD) was held by 89 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,546,722 shares. The largest 10 holders included FMR LLC, T. Rowe Price Investment Management, Inc., RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, RICE HALL JAMES & ASSOCIATES, LLC, Ranger Investment Management, L.P., STATE STREET CORP, and Russell Investments Group, Ltd.. This page lists 89 institutional shareholders reporting positions in this security for the Q2 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

Q2 2023 holders

Holder diff

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 Value $	Q2 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.